Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.
作者信息
Liang Yunan, Lin Han, Jiang Zongsheng, Zhao Qi, Cui Ri, Li Shaotang
机构信息
Department of Colorectal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang Street, Ouhai District, Wenzhou, 325000, Zhejiang, China.
Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Chashan Road, Wenzhou, 325035, Zhejiang, China.
出版信息
Discov Oncol. 2025 Jan 30;16(1):103. doi: 10.1007/s12672-024-01512-0.
Abstract
摘要
相似文献
1
Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.
Discov Oncol. 2025 Jan 30;16(1):103. doi: 10.1007/s12672-024-01512-0.
2
HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.
Discov Oncol. 2024 Oct 29;15(1):603. doi: 10.1007/s12672-024-01440-z.
3
HOXB8 enhances the proliferation and metastasis of colorectal cancer cells by promoting EMT via STAT3 activation.
Cancer Cell Int. 2019 Jan 3;19:3. doi: 10.1186/s12935-018-0717-6. eCollection 2019.
4
The roles of HOXB8 through activating Wnt/β-catenin and STAT3 signaling pathways in the growth, migration and invasion of ovarian cancer cells.
Cytotechnology. 2022 Feb;74(1):77-87. doi: 10.1007/s10616-021-00508-w. Epub 2022 Jan 3.
5
Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer.
Theranostics. 2019 Apr 12;9(8):2235-2251. doi: 10.7150/thno.30678. eCollection 2019.
6
Knock-Down of HOXB8 Prohibits Proliferation and Migration of Colorectal Cancer Cells via Wnt/β-Catenin Signaling Pathway.
Med Sci Monit. 2019 Jan 24;25:711-720. doi: 10.12659/MSM.912218.
7
Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.
Clin Cancer Res. 2014 Jul 15;20(14):3775-86. doi: 10.1158/1078-0432.CCR-13-2181. Epub 2014 May 8.
8
Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity.
Cancer Biol Ther. 2014 May;15(5):623-32. doi: 10.4161/cbt.28179. Epub 2014 Feb 20.
9
Exosome-derived lnc-HOXB8-1:2 induces tumor-associated macrophage infiltration to promote neuroendocrine differentiated colorectal cancer progression by sponging hsa-miR-6825-5p.
BMC Cancer. 2022 Aug 27;22(1):928. doi: 10.1186/s12885-022-09926-1.
10
Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.
Clin Cancer Res. 2012 Sep 15;18(18):4986-96. doi: 10.1158/1078-0432.CCR-12-0792. Epub 2012 Jul 23.
本文引用的文献
1
HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway.
Discov Oncol. 2024 Oct 29;15(1):603. doi: 10.1007/s12672-024-01440-z.
Zotero 插件